VS
Veera Sura Prasad Damarla
About Veera Sura Prasad Damarla
Data last updated:
Veera Sura Prasad Damarla is a Director at Bactolac Formulations Pvt Ltd (since 2024) and Director at Biotec Medicaments India Private Limited (since 2014). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹20.29 Cr; the largest is Bactolac Formulations Pvt Ltd at ₹20.27 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bactolac Formulations Pvt Ltd U24230TG1993PTC015641 | Director | 02 Dec 2024 | 1993 | ₹20.27 Cr (FY 2025) | Active |
| Biotec Medicaments India Private Limited U24233TG2014PTC096816 | Director | 12 Dec 2014 | 2014 | ₹2.2 Lakh (FY 2022) | Active |
Board colleagues of Veera Sura Prasad Damarla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Syamala Rani Kanuri | 07178499 | Bactolac Formulations Pvt Ltd | Director |
| Shruti Prasad Arrivilla | 09333304 | Biotec Medicaments India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Veera Sura Prasad Damarla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Veera Sura Prasad Damarla
Veera Sura Prasad Damarla currently holds 2 directorships: Bactolac Formulations Pvt Ltd (Director, since 02 Dec 2024, revenue ₹20.27 Cr (FY 2025)); Biotec Medicaments India Private Limited (Director, since 12 Dec 2014, revenue ₹2.2 Lakh (FY 2022)).
Veera Sura Prasad Damarla was first appointed on 12 Dec 2014 as Director at Biotec Medicaments India Private Limited. The most recent appointment on record is 02 Dec 2024 at Bactolac Formulations Pvt Ltd.
The 2 current companies of Veera Sura Prasad Damarla that report revenue have a combined latest revenue of ₹20.29 Cr: Bactolac Formulations Pvt Ltd ₹20.27 Cr (FY 2025); Biotec Medicaments India Private Limited ₹2.2 Lakh (FY 2022).
The current boards of Veera Sura Prasad Damarla's companies include Syamala Rani Kanuri (Bactolac Formulations Pvt Ltd), Shruti Prasad Arrivilla (Biotec Medicaments India Private Limited).